New Jersey, United States, July 2026 — Johnson & Johnson has elevated Sarah Freeman to the position of Vice President, Global Oncology Communications & Public Affairs, effective June 2026. In this expanded leadership role, she will continue to shape the global communications and public affairs strategy for the company’s oncology business, supporting its mission to advance innovative treatments for patients worldwide.
With over 20 years of experience in healthcare communications, corporate affairs, and strategic marketing, Sarah Freeman has built an accomplished career driving communications strategies for leading global healthcare organizations. She has been with Johnson & Johnson for more than 10 years, steadily advancing through leadership roles across therapeutic communications, executive communications, research and development, and oncology.
Prior to her elevation, Sarah served as Global Head, Oncology Communications & Public Affairs, where she led communications for Johnson & Johnson’s industry-leading oncology portfolio spanning hematology and solid tumors. Earlier, she held the roles of Senior Director, Global Executive Communications & Business Development, Innovative Medicine, Senior Director, Global Therapeutic Area Communications Lead – R&D, and Director, Business Unit Communication, Cardiovascular & Metabolism, playing a pivotal role in strengthening executive messaging, business development communications, and therapeutic area engagement.
Before joining Johnson & Johnson, Sarah spent nearly six years with Novo Nordisk, where she held progressive leadership positions in global marketing and product communications. Earlier in her career, she gained valuable experience with Calcium USA, Dorland Global Public Relations, MSLGROUP, the National Parks Conservation Association, and the United Nations Foundation, building a strong foundation in public relations, stakeholder engagement, and strategic communications.
Sarah’s elevation reflects her proven ability to lead high-impact global communications initiatives, strengthen corporate reputation, and support the advancement of innovative healthcare solutions through strategic public affairs and stakeholder engagement.
About Johnson & Johnson
Johnson & Johnson is one of the world’s leading healthcare companies, driven by the belief that health is the foundation of everything. Through its expertise in Innovative Medicine and MedTech, the company develops breakthrough healthcare solutions that help prevent, treat, and cure complex diseases while making treatments smarter, less invasive, and more personalized.
With a long-standing commitment to scientific innovation and improving patient outcomes, Johnson & Johnson continues to advance healthcare globally by delivering transformative medicines, medical technologies, and solutions that positively impact millions of lives around the world.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
